Zhejiang Conba Pharmaceutical Hits Day Low Amid Price Pressure at CNY 4.04

Zhejiang Conba Pharmaceutical Co., Ltd. experienced a significant decline in its stock performance today, with a drop of 6.02% on March 23, 2026. The stock reached an intraday low of CNY 4.04, reflecting a challenging trading session for the company. Over the past week, the stock has seen a decrease of 8.56%, while its performance over the last month shows a decline of 8.35%. In a broader context, the stock has underperformed compared to the China Shanghai Composite index, which has seen a decline of 3.63% today and 6.65% over the past week. Looking at longer-term trends, Zhejiang Conba has faced a 9.58% drop over the past year, contrasting sharply with the 13.33% gain of the Shanghai Composite during the same period. The company's market capitalization stands at CNY 11,156 million, and it maintains a price-to-earnings ratio of 20.00. Despite the recent downturn, the company offers a dividend yield of 3.46%, indicating a potential return for shareholders amidst the current market fluctuations.